APA (7th ed.) Citation

Gurumurthi, A., Bantilan, K. S., Hamlin, P. A., Kumar, A., Matasar, M., Zhu, M., . . . von Keudell, G. (2024). A phase 1 trial of abexinostat with ibrutinib in relapsed/refractory mantle cell lymphoma and non-germinal center diffuse large B cell lymphoma. Leukemia & Lymphoma, 65(14), 2224. https://doi.org/10.1080/10428194.2024.2398658

Chicago Style (17th ed.) Citation

Gurumurthi, Ashwath, et al. "A Phase 1 Trial of Abexinostat with Ibrutinib in Relapsed/refractory Mantle Cell Lymphoma and Non-germinal Center Diffuse Large B Cell Lymphoma." Leukemia & Lymphoma 65, no. 14 (2024): 2224. https://doi.org/10.1080/10428194.2024.2398658.

MLA (9th ed.) Citation

Gurumurthi, Ashwath, et al. "A Phase 1 Trial of Abexinostat with Ibrutinib in Relapsed/refractory Mantle Cell Lymphoma and Non-germinal Center Diffuse Large B Cell Lymphoma." Leukemia & Lymphoma, vol. 65, no. 14, 2024, p. 2224, https://doi.org/10.1080/10428194.2024.2398658.